Back to Search
Start Over
Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients.
- Source :
- EJHaem; Nov2020, Vol. 1 Issue 2, p507-516, 10p
- Publication Year :
- 2020
Details
- Language :
- English
- Volume :
- 1
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- EJHaem
- Publication Type :
- Academic Journal
- Accession number :
- 146948755
- Full Text :
- https://doi.org/10.1002/jha2.111